MSI Methylation is a pharmaceutical company that develops molecule therapies for the treatment of Major Depressive Disorder... Read more
MSI Methylation is a pharmaceutical company that develops molecule therapies for the treatment of Major Depressive Disorder... Read more
News
Apr 16, 2019
GlobalNewswire
Press Release: MSI Methylation Sciences : MSI Methylation Sciences, Inc. (MSI) Update on Recent BC Supreme Court Order for Quark Venture Inc. (Quark) to Pay MSI $20 million USD
Oct 18, 2018
GlobeNewswire
Press Release: MSI Methylation Sciences : MSI Methylation Sciences, Inc. (MSI) provides an update on its corporate activities, including its recent arbitration award of $20 million USD against Quark Venture Inc (Quark)
Oct 07, 2016
PE Hub Network
MSI: MSI rakes in $300 mln from Quark Venture
Jan 27, 2016
BioSpace
MSI: MSI Methylation Sciences (MSI) Announces Results From The Horizon Phase 2 Trial For Its Novel Treatment, MSI-195, For Major Depressive Disorder (MDD)
Jan 26, 2016
FinanzNachrichten
MSI: MSI Methylation Sciences Inc. (MSI) Announces Results From the Horizon Phase 2 Trial for its Novel Treatment, MSI-195, for Major Depressive Disorder (MDD)
Aug 25, 2015
FINANZNACHRICHTEN.DE
MSI: MSI Methylation Sciences Inc. (MSI) Treats the Last Patient in its Horizon Trial and Receives Four Patents to Support its Proprietary Treatment Strada for Major Depressive Disorder (MDD)
Aug 25, 2015
MARKETWIRED
Press Release: MSI : MSI Methylation Sciences Inc. (MSI) Treats the Last Patient in its Horizon Trial and Receives Four Patents to Support its Proprietary Treatment Strada(TM) for Major Depressive Disorder (MDD)
May 07, 2015
BIOSPACE
MSI: <b>MSI Methylation Sciences, Inc. (MSI)</b> Completes Recruitment Of Phase 2 Trial For Its Novel Treatment STRADA For Major Depressive Disorder (MDD)
May 07, 2015
PR NEWSWIRE
Press Release: MSI : MSI Methylation Sciences, Inc. (MSI) Completes Recruitment of Phase 2 Trial for its Novel Treatment STRADA for Major Depressive Disorder (MDD)
MSI Methylation Sciences Competitors
1
2
3
4
5
6
7
8
9
10